So we decided to explore whether endoplasmic reticulum (ER) stress activation could be the mode of action of BB-CLA in our canine and feline tumoral cells, based on a recent study where the activation of this pathway was demonstrated in estrogen receptor (ERα)-negative breast cancer cells using another PAD inhibitor [19, 30]. The gene discussed is PADI4; the disease is breast carcinoma.